Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FREQUENCY THERAPEUTICS, INC.

(FREQ)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
7.23(c) 7.3(c) 7.28(c) 7.51(c) 7.52(c) Last
404 034 114 879 431 770 131 022 140 630 Volume
+0.70% +0.97% -0.27% +3.16% +0.13% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 48,8 M - -
Net income 2021 -49,8 M - -
Net cash position 2021 99,4 M - -
P/E ratio 2021 -5,19x
Yield 2021 -
Sales 2022 14,5 M - -
Net income 2022 -122 M - -
Net cash position 2022 30,3 M - -
P/E ratio 2022 -2,61x
Yield 2022 -
Capitalization 259 M 259 M -
EV / Sales 2021 3,27x
EV / Sales 2022 15,8x
Nbr of Employees 85
Free-Float 87,1%
More Financials
Company
Frequency Therapeutics Inc. is a United States-based clinical-stage progenitor cell activation (PCA) regeneration company. The Company is focused on developing small molecule drugs that activate progenitor cells within the body to restore healthy tissue. It uses its PCA technology to develop a pipeline of progenitor cell activators. It focuses on various therapeutic areas, such as hearing loss, skin disorders,... 
Sector
Biotechnology & Medical Research
Calendar
11/09 | 08:30amR&D Day
More about the company
Ratings of Frequency Therapeutics, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D+
More Ratings
All news about FREQUENCY THERAPEUTICS, INC.
09/23JOHN CHEN : Stock Futures -3-
DJ
09/22FREQUENCY THERAPEUTICS : Frequently Therapeutics Says Drug Improves Hearing Over Extended ..
MT
09/22FREQUENCY THERAPEUTICS : Goldman Sachs Downgrades Frequency Therapeutics to Neutral Rating..
MT
09/22FREQUENCY THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statement..
AQ
09/22FREQUENCY THERAPEUTICS : Announces New FX-322 Results Showing That Additional Study Partic..
BU
09/22Frequency Therapeutics, Inc. Announces New FX-322 Results Showing that Additional Study..
CI
09/08FREQUENCY THERAPEUTICS : to Present at Upcoming Investor Conferences
BU
08/12FREQUENCY THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and R..
AQ
08/12FREQUENCY THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation F..
AQ
08/12FREQUENCY THERAPEUTICS : Earnings Flash (FREQ) FREQUENCY THERAPEUTICS Reports Q2 Revenue $..
MT
08/12FREQUENCY THERAPEUTICS : Provides Business Updates and Second Quarter 2021 Financial Resul..
BU
08/12Frequency Therapeutics, Inc. Announces Unaudited Consolidated Earnings Results for the ..
CI
07/30DEADLINE ALERT : Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit..
BU
07/30THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the Class Acti..
BU
07/28SHAREHOLDER ALERT : Pomerantz Law Firm Reminds Shareholders with Losses on their Investmen..
PR
More news
News in other languages on FREQUENCY THERAPEUTICS, INC.
03/24MILAN STOCK EXCHANGE : Borsa Milano in lieve rialzo con WS, pesante Leonardo, bene Eni, re..
03/24MILAN STOCK EXCHANGE : Borsa Milano piatta, tonfo per Leonardo, bene Stm, oil, realizzi su..
More news
Analyst Recommendations on FREQUENCY THERAPEUTICS, INC.
More recommendations
Chart FREQUENCY THERAPEUTICS, INC.
Duration : Period :
Frequency Therapeutics, Inc. Technical Analysis Chart | FREQ | US35803L1089 | MarketScreener
Technical analysis trends FREQUENCY THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 7,52 $
Average target price 12,75 $
Spread / Average Target 69,5%
EPS Revisions
Managers and Directors
David L. Lucchino President, Chief Executive Officer & Director
Peter P. Pfreundschuh Chief Financial Officer
Marc A. Cohen Chairman
Christopher R. Loose Chief Scientific Officer
Dana Charles Hilt Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
FREQUENCY THERAPEUTICS, INC.-78.67%259
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353